Demirci H - Search Results

1

Effects of daily telephone-based re-education before taking medicine on Helicobacter pylori eradication.

Demirci H, Ozturk K, Kurt O. Demirci H, et al. World J Gastroenterol. 2016 Apr 21;22(15):4071-2. doi: 10.3748/wjg.v22.i15.4071. World J Gastroenterol. 2016. PMID: 27099453 Free PMC article.

2

Influence of vitamin C and E supplementation on the eradication rates of triple and quadruple eradication regimens for Helicobacter pylori infection.

Demirci H, Uygun İlikhan S, Öztürk K, Üstündağ Y, Kurt Ö, Bilici M, Köktürk F, Uygun A. Demirci H, et al. Turk J Gastroenterol. 2015 Nov;26(6):456-60. doi: 10.5152/tjg.2015.0233. Epub 2015 Oct 26. Turk J Gastroenterol. 2015. PMID: 26510082 Free article.

3

High-dose dual therapy is effective as first-line treatment for Helicobacter pylori infection.

Öztürk K, Kurt Ö, Çelebi G, Şarlak H, Karakaya MF, Demirci H, Kılınç A, Uygun A. Öztürk K, et al. Among authors: demirci h. Turk J Gastroenterol. 2020 Mar;31(3):234-238. doi: 10.5152/tjg.2020.18974. Turk J Gastroenterol. 2020. PMID: 32343235 Free PMC article.

4

Helicobacter Pylori Colonization Density is an Important Risk Factor for Eradication Therapy.

Demirci H, Ozturk K, Tanoglu A, Kilciler AG, Gunal A, Gulsen M, Uygun A. Demirci H, et al. J Gastrointestin Liver Dis. 2022 Jun 12;31(2):163-167. doi: 10.15403/jgld-4238. J Gastrointestin Liver Dis. 2022. PMID: 35574618 Free article.

5

The cumulative colectomy rate in patients with cytomegalovirus-positive ulcerative colitis.

Ozturk K, Demirci H, Kantarcioglu M, Uygun A, Bagci S. Ozturk K, et al. Among authors: demirci h. Gut Liver. 2015 Mar;9(2):253. doi: 10.5009/gnl14450. Gut Liver. 2015. PMID: 25721005 Free PMC article. No abstract available.

6

Effect of ursodeoxycholic acid on atherosclerosis.

Ozturk K, Uygun A, Demirci H, Bagci S. Ozturk K, et al. Among authors: demirci h. Eur J Gastroenterol Hepatol. 2015 Jul;27(7):865. doi: 10.1097/MEG.0000000000000365. Eur J Gastroenterol Hepatol. 2015. PMID: 26039180 No abstract available.

7

Neutrophil-to-lymphocyte ratio for predicting fibrosis in nonalcoholic fatty liver disease.

Ozturk K, Altun B, Kurt O, Demirci H. Ozturk K, et al. Among authors: demirci h. Eur J Gastroenterol Hepatol. 2015 Dec;27(12):1479. doi: 10.1097/MEG.0000000000000475. Eur J Gastroenterol Hepatol. 2015. PMID: 26513521 No abstract available.

8

Pentraxin 3 Is a Predictor for Fibrosis and Arterial Stiffness in Patients with Nonalcoholic Fatty Liver Disease.

Ozturk K, Kurt O, Dogan T, Ozen A, Demirci H, Yesildal F, Kantarcioglu M, Turker T, Guler AK, Karslioglu Y, Altun B, Uygun A, Bagci S. Ozturk K, et al. Among authors: demirci h. Gastroenterol Res Pract. 2016;2016:1417962. doi: 10.1155/2016/1417962. Epub 2016 Feb 22. Gastroenterol Res Pract. 2016. PMID: 26997950 Free PMC article.

9

Predictors of steatohepatitis in nonalcoholic fatty liver disease.

Ozturk K, Demirci H, Kurt O. Ozturk K, et al. Among authors: demirci h. Eur J Gastroenterol Hepatol. 2016 May;28(5):606-7. doi: 10.1097/MEG.0000000000000575. Eur J Gastroenterol Hepatol. 2016. PMID: 27010475 No abstract available.

10

Is nonalcoholic fatty liver disease a risk factor for chronic kidney disease?

Ozturk K, Demirci H, Kurt O, Kantarcioglu M. Ozturk K, et al. Among authors: demirci h. Eur J Gastroenterol Hepatol. 2016 May;28(5):608-9. doi: 10.1097/MEG.0000000000000582. Eur J Gastroenterol Hepatol. 2016. PMID: 27010477 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

412 results

Search Page